Adjunctive treatment with low-dosage pramipexole for risperidone-associated hyperprolactinemia and sexual dysfunction in a male patient with schizophrenia.

Ishitobi M, Kosaka H, Shukunami K-ichi, Murata T, Wada Y. Adjunctive treatment with low-dosage pramipexole for risperidone-associated hyperprolactinemia and sexual dysfunction in a male patient with schizophrenia. J Clin Psychopharmacol. 2011;31(2):243-5. DOI: 10.1097/JCP.0b013e31820f4fbd. PubMed PMID: 21364336.

Olanzapine use in women with antipsychotic-induced hyperprolactinemia.

Canuso CM, Hanau M, Jhamb KK, Green AI. Olanzapine use in women with antipsychotic-induced hyperprolactinemia. AJP. 1998;155(10):1458. DOI: 10.1176/ajp.155.10.1458. PubMed PMID: 9766782.

Prevalence of hyperprolactinemia in schizophrenia: association with typical and atypical antipsychotic treatment.

Montgomery J, Winterbottom E, Jessani M, Kohegyi E, Fulmer J, Seamonds B, et al. Prevalence of hyperprolactinemia in schizophrenia: association with typical and atypical antipsychotic treatment. J Clin Psychiatry. 2004;65(11):1491-8. PubMed PMID: 15554761.

Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.

Kapur S, Seeman P. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis. Am J Psychiatry. 2001;158(3):360-9. DOI: 10.1176/appi.ajp.158.3.360. PubMed PMID: 11229973.

Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin).

Kelly DL, Wehring HJ, Earl AK, Sullivan KM, Dickerson FB, Feldman S, et al. Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin). Bmc Psychiatrybmc Psychiatry. 2013;13:214. DOI: 10.1186/1471-244X-13-214. PubMed PMID: 23968123; PubMed Central PMCID: PMC3766216.

Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine.

Kinon BJ, Ahl J, Liu-Seifert H, Maguire GA. Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine. Psychoneuroendocrinology. 2006;31(5):577-88. DOI: 10.1016/j.psyneuen.2005.12.006. PubMed PMID: 16488084.

Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.

Lu M-L, Shen WW, Chen C-H. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(8):1978-81. DOI: 10.1016/j.pnpbp.2008.09.016. PubMed PMID: 18848860.

Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone.

Kim K-S, Pae C-U, Chae J-H, Bahk W-M, Jun T-Y, Kim D-J, et al. Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone. J Clin Psychiatry. 2002;63(5):408-13. PubMed PMID: 12019665.

Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study.

Byerly MJ, Marcus RN, Tran Q-V, Eudicone JM, Whitehead R, Baker RA. Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study. Schizophr Res. 2009;107(2-3):218-22. DOI: 10.1016/j.schres.2008.09.019. PubMed PMID: 19038534.

Dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia.

Yasui-Furukori N, Furukori H, Sugawara N, Fujii A, Kaneko S. Dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia. J Clin Psychopharmacol. 2010;30(5):596-9. DOI: 10.1097/JCP.0b013e3181ee832d. PubMed PMID: 20814333.